S&P 500 Earnings: These Expected EPS Growth Rates For Forward Quarters Seem Unsustainable

The forward 4-quarter S&P 500 EPS estimate rose to $353.22 this week, up from $352.62 last week and $338.29 at the start of the quarter. Q1 '26 S&P 500 EPS growth has accelerated to +29.4% from an expected +14.4% on April 3, and Q2 '26 is starting at a robust +24% growth rate. The update points to stronger-than-expected earnings momentum for the index, though the article is primarily an estimate revision rather than a hard catalyst.

Analysis

The steady rise in forward earnings is less about the index level and more about the cost of capital regime. When the market can keep ratcheting estimates higher without a corresponding deterioration in valuation, the natural beneficiary is quality duration: mega-cap growth, semis, and software can compound at higher multiples because the buyback/earnings-support loop stays intact. The second-order loser is the high-debt, low-visibility cohort in industrials, consumer discretionary, and smaller cyclical names, where higher estimate dispersion will likely widen and capital will continue to concentrate in the few firms that can actually deliver 20%+ EPS growth.

The bigger setup is that the bar for Q2 will likely become the next squeeze point. If estimates are already starting the quarter at a very elevated growth rate, any inline results may be treated as a miss by price action standards, while upside revisions become more valuable than beats. That favors firms with self-help levers—margin expansion, pricing power, and aggressive repurchases—because they can sustain estimate momentum even if revenue growth cools.

Contrarian risk: the market may be extrapolating earnings breadth from a narrow set of beneficiaries. Estimate upgrades often lag price and can reflect momentum chasing rather than fundamental diffusion, so this can reverse quickly if margins normalize, labor costs re-accelerate, or guidance turns conservative in the first two weeks of reporting season. The near-term risk window is days to weeks around earnings preannouncements; the medium-term reversal window is 1-2 quarters if forward revisions stop broadening beyond the top ten mega-caps.

Key Decisions for Investors

• Overweight QQQ vs. IWM for the next 4-8 weeks: the revision cycle is still favoring large-cap earnings compounding, and small caps are more exposed if forward growth breadth stays narrow.
• Go long SMH / short XLI into Q2 earnings season: semis are better positioned to convert estimate momentum into price support, while industrials are more vulnerable to margin disappointment if the market starts demanding proof instead of promises.
• Buy MSFT or META on post-earnings volatility dips over the next 1-2 months: both have the balance-sheet and buyback capacity to defend elevated forward estimates, giving a better risk/reward than names relying purely on multiple expansion.
• Consider a pair trade long XLG / short equal-weight S&P (RSP) for 1-3 months: if forward EPS breadth remains concentrated, cap-weighted index exposure should outperform equal-weight by 200-400 bps as revision leadership stays narrow.
• For downside protection, own short-dated QQQ put spreads around the first major earnings week: if the market begins to treat good results as not-good-enough, implied vol should stay bid and a defined-risk hedge can pay quickly.